Latest Press Releases

Thermo Fisher Scientific Launches Ion AmpliSeq HD Technology

New library preparation solution for targeted next-generation sequencing is first to combine gene panel design customization with ultra-high sensitivity ...

GammaDelta Therapeutics Appoints Michael Koslowski as CMO

LONDON , June 18, 2018 /PRNewswire/ -- GammaDelta Therapeutics Ltd, an emerging biotech company developing novel immunotherapies for cancer and other diseases announced today that it has strengthened its leadership team with the appointment of Michael Koslowski , MD, as Chief Medical Officer....

Triad Of Health Family Healing Center Reveals The Seven Pitfalls You Must Avoid To Heal Your Thyroid

Dr. Ilya Skolnikoff, DC, DIBAK, Clinic Director of Triad Of Health Family Healing Center in Northern California has been helping his patients to heal from autoimmune thyroid disorders such as Hashimoto's Thyroiditis and Graves Disease using a variety of non-surgical methods. SAN RAFAEL, Calif....

Presenting New York's Periodontics and Dental Implant Specialist, Cynthia Gomez, DDS

Cynthia Gomez, DDS has been reviewed and approved by NY Top Dentists for 2018. SCOTCH PLAINS, N.J. , June 18, 2018 /PRNewswire-PRWeb/ -- NY Top Dentists is proud to present Periodontist, Cynthia Gomez , DDS for 2018. Dr. Gomez is located in Midtown Manhattan and strives to provide personali...

Health Ingredients China: Opening its Doors This Week

AMSTERDAM , June 18, 2018 /PRNewswire/ -- We look forward to welcoming you to Shanghai this week for Health ingredients China 2018, China's leading health industry event. Over the course of three days, Hi China together with its co-located events will offer you access to the most innovat...

Continued Discussions With FDA on Proposed Remetinostat Phase III Design Results in Delay in Planned Start of Study

http://mb.cision.com/Main/652/2550721/861953.pdf Press release (PDF) ...

NeuroVive out-licenses targeted LHON therapy to BridgeBio Pharma's new subsidiary Fortify Therapeutics

LUND, Sweden and PALO ALTO, Calif., June 18, 2018 /PRNewswire/ -- NeuroVive Pharmaceutical AB and BridgeBio Pharma today jointly announced that BridgeBio has entered into an exclusive licensing agreement for a subset of succinate prodrug chemistry under NeuroVive's NVP015 program. BridgeBio a...

Dr Batra's Geno Homeopathy Redefines the Future of Healing - Introducing for the First Time in India a Revolutionary, Scientific, Safe and Precise Gene-targeted Homeopathic Therapy

MUMBAI , June 18, 2018 /PRNewswire/ -- Having carved a distinct niche for itself in the last four decades globally in the field of Homeopathy, Dr Batra's Multi-Specialty Homeopathy Clinics today revolutionized the future of healing by launching Dr Batra's Geno Homeopathy , a revolutionary and...

A diabetes diagnosis later in life may signal early pancreatic cancer in African Americans and Latinos

A new study from the Keck School of Medicine of USC shows that African Americans and Latinos who are diagnosed with diabetes after age 50 are at increased risk of developing one of the deadliest forms of cancer LOS ANGELES , June 17, 2018 /PRNewswire-USNewswire/ -- Each year, more than one m...

Rep. Reed Breaks with GOP to Defend Pre-Existing Conditions

...

Kanazawa University Research: Lipids and Proteins: Further Evidence for Functional Crosstalk in Cells

KANAZAWA, Japan , June 17, 2018 /PRNewswire/ -- Researchers at Kanazawa University have uncovered the role of lipids in facilitating a functional switch between two forms of a cellular enzyme: Peroxiredoxin (Prxs). Their study published in the Journal of Molecular Biology explains how negative...

Aprea Therapeutics Presents Results From Phase Ib/II Clinical Study of APR-246 and Azacitidine (AZA) in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) at the 2018 European Hematology Association (EHA) Annual Meeting in Stockholm

- ORR (by IWG) of 100% in all evaluable patients: 8 CR (89%) and 1 mCR (11%) ...

Updated Preliminary Data from SMA FIREFISH Program in Type 1 Babies Presented at the CureSMA Conference

- risdiplam (RG7916) is well tolerated at all dose levels with no drug-related safety findings - SOUTH PLAINFIELD, N.J. , June 16, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the presentation of updated interim clinical data from Part 1 of the FIREFISH study ...

Phase 3 QuANTUM-R Study Demonstrates Daiichi Sankyo's Quizartinib Significantly Prolongs Overall Survival as Single Agent Compared to Chemotherapy in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations

-- Data from QuANTUM-R presented as a late-breaking oral presentation during plenary session at 23rd Congress of the European Hematology Association (EHA) TOKOYO, MUNICH , and BASKING RIDGE, N.J. , June 16, 2018 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) ann...

'Build a Bond' – A Himalaya Companion Care Initiative to Drive Pet Adoption

BENGALURU, India , June 16, 2018 /PRNewswire/ -- The Himalaya Drug Company today organized a pet adoption drive, 'Build a Bond', at The Lalit Ashok, Bengaluru. Committed to supporting this cause, the event organized in the city, witnessed over 165 furry friends along with their parents. The e...

/R E P E A T -- Media Advisory - New Report on Child Poverty by Federal Ridings/

TORONTO , June 15, 2018 /CNW/ - Campaign 2000 will release a report on Child Poverty by Ridings on Monday June 18, 2018 . The media release, full report, companion data and infographics will be available at www.campaign2000.ca as of 12:01 am . The report anticipates the release of Canada...

Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL

Overall response rate was 52% and median duration of response was not reached at a median follow-up of 14 months, signifying responses were durable (1) Novartis Investor Relations Central investor relations line: +41 61 324 7944 E-mail: investor.relations@novartis.com ...

European Hematology Association: iNNOVATE Study: Ibrutinib Plus Rituximab for Patients With Waldenström's Macroglobulinemia

STOCKHOLM , June 16, 2018 /PRNewswire/ -- Waldenström's Macroglobulinemia (WM) is a rare type of blood cancer. Since WM is rare, it is difficult to conduct large clinical studies and determine a standard treatment for the disease. Rituximab, a therapy used to treat other types of blood cancer,...

European Hematology Association: Answering the Unmet Need in One of the Most Common Types of Lymphoma: It's as Simple as A-D-C

STOCKHOLM , June 16, 2018 /PRNewswire/ -- Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Unfortunately, 40% of patients will relapse after or not respond to initial treatment resulting in poor outcomes especially if stem cell transplant is not an option....

European Hematology Association: A New Anti-CD22 CAR-T Immunotherapy Saved Life of Children With Leukemia

STOCKHOLM , June 16, 2018 /PRNewswire/ -- B acute lymphoblastic leukemia (B-ALL) is a fatal blood cell tumor that is usually treated with chemotherapy or allogeneic hematopoietic stem cell transplantation (allo-HCT), and CD19-CAR-T cell therapy has been successful in treating refractory or rel...

SOPHiA GENETICS Acquires Interactive Biosoftware to Drive Growth and Accelerate Data-Driven Medicine Adoption Around the World

MILAN , June 16, 2018 /PRNewswire/ -- SOPHiA GENETICS, global leader in Data-Driven Medicine, announced today at the European Human Genetics Conference (ESHG 2018) that it has completed the acquisition of French-based tech company Interactive Biosoftware (IBS) , the creators of Alamut ® , the...

ZEISS unveils next generation of ophthalmic laser VISULAS green at World Ophthalmology Congress

...

Women's Excellence Welcomes Suzana Marku, Nurse Practitioner

Women's Excellence in Obstetrics and Gynecology welcomes Suzana Marku, NP, to their team of Nurse Practitioners. LAKE ORION, Mich. , June 16, 2018 /PRNewswire-PRWeb/ -- Suzana is a Family Nurse Practitioner and is nationally certified through the American Association of Nurse Practitioner (A...

Calif. Appeals Court Suspends Lower Court Ruling, Reinstates End of Life Option Act

Ruling Allows Terminally Ill Californians to Use Law to Die Peacefully ...

Indivior Is Granted Temporary Restraining Order

SLOUGH, England , June 15, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. District Court for the District of New Jersey has granted Indivior a temporary restraining order (TRO) that compels Dr. Reddy's (DRL) to immediately cease its lau...

MedVet President and CEO, Dr. Eric Schertel, Recognized as a Member of the Smart 50 2018 Class

Recognizing Central Ohio leaders' ability to effectively build and lead successful organizations, Smart Business awarded Dr. Eric Schertel, President and CEO of MedVet, a seat as a member of the Smart 50 class of 2018. Schertel is a two time recipient of this award recognizing his leadership at Med...

Global Cosmetic Antioxidants Market Forecast to 2023: Market is Driven by a Rise in Aging Population, Increasing Disposable Income, and Changing Lifestyle

...

Global Creatinine Measurement 2018-2023: Commercialization of Advanced Testing Methods Presents Market Opportunities

...

Study Showcases how Medical Affairs Provides Value to External Stakeholders Such as Payers and Specialty Pharmacies

CHAPEL HILL, N.C. , June 15, 2018 /PRNewswire/ -- Medical Affairs has long been a key function within the pharmaceutical industry because of its role in providing medical information to external stakeholder groups. As emerging groups such as payers, Accountable Care Organizations, specialty ph...

Charles William Wilcox, DDS is recognized by Continental Who's Who

PAPILLION, Neb. , June 15, 2018 /PRNewswire/ -- Charles William Wilcox , DDS is recognized by Continental Who's Who as a Professional of the Year in the field of Dentistry in recognition of his role as Prosthodontist at Charles William Wilcox, DDS and Professor Emeritus at Creighton Univers...